Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Catheter Ablation of Atrial Fibrillation Using Hansen Medical Robotic Navigation

NCT01037296 · Barts & The London NHS Trust · Updated 10 July 2014

What is being tested
catheter ablation; catheter ablation
For
Atrial Fibrillation
Kind of study
Tests a treatment or device on volunteers. Phase 4.
Who can join
Ages 18 years and older. About 166 people. The full rules are on the registry page.
Where
United Kingdom
When
Starts or started April 2008, ends Sept 2013. Registered 23 Dec 2009.
Results
None posted yet.

In the researchers' words

Atrial fibrillation (AF) affects as many as 1 in 100 people and reduces the quality of life of large numbers of people in the UK and around the world. Catheter ablation is a minimally invasive treatment that has been developed to help eliminate AF. It is a complex procedure to perform so only a few hospitals are able to offer this treatment in the UK. A new technology allows the operator to guide their catheters (thin wires) in the patient by using a robotically steered sheath. This allows accurate and precise navigation that may improve the accuracy and integrity of ablation. We aim to prove whether this technology can make AF ablation easier and more effective. Substudy: Platelet reactivity and activation in AF, and the impact of curative ablation. Blood and urine samples will be taken pre- and 3 months post ablation to see if platelet reactivity and activation are affected by AF compared to established normal ranges, and whether curative ablation impacts on this.
ClinicalTrials.gov, NCT01037296

Sites

  • Barts and the London NHS TrustLondon, London, United Kingdom